Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis
NTRK1 (TRKA)/ NTRK2 (TRKB) (Tyr)
Tyrosine kinase
Inhibitor discovery & SARSelectivity & kinome profilingMechanism & structural biology
AQT co-authored
